Nanotechnology and nanomedicine in cardiovascular therapy - Biomaterials and Devices for the Circulatory System - page 256

tumours, for example by the incorporation of doxorubicin and paclitaxel
into magnetic nanoparticles which can be imaged by MRI and have dem-
onstrated antiproliferative activity in MCF-7 cells (a breast cancer cell line
with characteristics of differentiated mammary epithelium). (Jain et al. ,
2008)
Despite the time lag in their development, there is huge potential in
investing in nanotechnology in cardiovascular disease (Lanza et al. , 2002).

9.5 References
AKERMAN, M. E., CHAN, W. C., LAAKKONEN, P., BHATIA, S. N. & RUOSLAHTI, E. (2002)
Nanocrystal targeting in vivo . Proc Natl Acad Sci USA , 99 , 12617-21.
ALRIC, C., TALEB, J., LE DUC, G., MANDON, C., BILLOTEY, C., LE MEUR-HERLAND, A.,
BROCHARD, T., VOCANSON, F., JANIER, M., PERRIAT, P., ROUX, S. & TILLEMENT, O. (2008)
Gadolinium chelate coated gold nanoparticles as contrast agents for both X-ray
computed tomography and magnetic resonance imaging. J Am Chem Soc , 130 ,
5908-15.
ALSBERG, E., FEINSTEIN, E., JOY, M. P., PRENTISS, M. & INGBER, D. E. (2006) Magnetically-
guided self-assembly of fi brin matrices with ordered nano-scale structure for
tissue engineering. Tissue Eng , 12 , 3247-56.
ARUMUGANATHAR, S., IRVINE, S., MCEWAN, J. R. & JAYASINGHE, S. N. (2007) Pressure-
assisted cell spinning: a direct protocol for spinning biologically viable cell-
bearing fi bres and scaffolds. Biomed Mater , 2 , 211-19.
BAKALOVA, R., ZHELEV, Z., AOKI, I., MASAMOTO, K., MILEVA, M., OBATA, T., HIGUCHI, M.,
GADJEVA, V. & KANNO, I. (2008) Multimodal silica-shelled quantum dots: direct
intracellular delivery, photosensitization, toxic, and microcirculation effects. Bio-
conjug Chem , 19 , 1135-42.
BATEMAN, R. M., HODGSON, K. C., KOHLI, K., KNIGHT, D. & WALLEY, K. R. (2007) Endotox-
emia increases the clearance of mPEGylated 5000-MW quantum dots as revealed
by multiphoton microvascular imaging. J Biomed Opt , 12 , 064005.
BLANKENBURG, F. G., MARI, C. & STRAUSS, H. W. (2002) Development of radiocontrast
agents for vascular imaging: progress to date. Am J Cardiovasc Drugs , 2 (6),
357-65.
BRIDOT, J. L., FAURE, A. C., LAURENT, S., RIVIERE, C., BILLOTEY, C., HIBA, B., JANIER, M.,
JOSSERAND, V., COLL, J. L., ELST, L. V., MULLER, R., ROUX, S., PERRIAT, P. & TILLEMENT,
O. (2007) Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for
in vivo imaging. J Am Chem Soc , 129 , 5076-84.
BRITZ-CUNNINGHAM, S. H. & ADELSTEIN, S. J. (2003) Molecular targeting with radionu-
clides: state of the science. J Nucl Med , 44 (12), 1945-61.
BURRI, P. H., HLUSHCHUK, R. & DJONOV, V. (2004) Intussusceptive angiogenesis: its
emergence, its characteristics, and its signifi cance. Dev Dyn , 231 , 474-88.
CAI, Q. Y., KIM, S. H., CHOI, K. S., KIM, S. Y., BYUN, S. J., KIM, K. W., PARK, S. H., JUHNG, S. K.
& YOON, K. H. (2007) Colloidal gold nanoparticles as a blood-pool contrast agent
for X-ray computed tomography in mice. Invest Radiol , 42 , 797-806.
CARD, J. W., ZELDIN, D. C., BONNER, J. C. & NESTMANN, E. R. (2008) Pulmonary applica-
tions and toxicity of engineered nanoparticles. Am J Physiol Lung Cell Mol
Physiol , 295 , L400-11.

￿ ￿ ￿ ￿ ￿